Late-life rapamycin treatment reverses age-related heart dysfunction
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Late-life rapamycin treatment reverses age-related heart dysfunction
Authors
Keywords
-
Journal
AGING CELL
Volume 12, Issue 5, Pages 851-862
Publisher
Wiley
Online
2013-06-04
DOI
10.1111/acel.12109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice
- (2013) Yimin Fang et al. Cell Metabolism
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Cardiac mTOR protects the heart against ischemia-reperfusion injury
- (2012) Toshinori Aoyagi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- A novel library screen identifies immunosuppressors that promote osteoblast differentiation
- (2012) Ariana Darcy et al. BONE
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Age-related loss of muscle fibres is highly variable amongst mouse skeletal muscles
- (2011) Philip W. Sheard et al. BIOGERONTOLOGY
- Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass
- (2011) Craig A. Goodman et al. CELLULAR SIGNALLING
- Echocardiographic Speckle-Tracking Based Strain Imaging for Rapid Cardiovascular Phenotyping in Mice
- (2011) Michael Bauer et al. CIRCULATION RESEARCH
- Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
- (2011) Toshinori Aoyagi et al. CURRENT PHARMACEUTICAL DESIGN
- Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides
- (2011) Toshio Nishikimi et al. Journal of Cardiology
- Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity
- (2011) Shi-Bing Yang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The Evolving Role of mTOR Inhibition in Transplantation Tolerance
- (2011) G. McMahon et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A guide to analysis of mouse energy metabolism
- (2011) Matthias H Tschöp et al. NATURE METHODS
- Rodent Models of Aging Bone: An Update
- (2011) Farhan A. Syed et al. Current Osteoporosis Reports
- mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy
- (2010) Xiaoxiao Song et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Coupling Vascular and Myocardial Inflammatory Injury into a Common Phenotype of Cardiovascular Dysfunction: Systemic Inflammation and Aging – A Mini-Review
- (2010) Valentina O. Puntmann et al. GERONTOLOGY
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
- (2010) Richard A. Miller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
- (2010) T E Witzig et al. LEUKEMIA
- Inflammatory networks during cellular senescence: causes and consequences
- (2010) Adam Freund et al. TRENDS IN MOLECULAR MEDICINE
- Overexpression of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging
- (2009) Dao-Fu Dai et al. CIRCULATION
- Rad As a Novel Regulator of Excitation–Contraction Coupling and β-Adrenergic Signaling in Heart
- (2009) Gang Wang et al. CIRCULATION RESEARCH
- Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function
- (2009) Yukio Mizuguchi et al. Journal of Cardiology
- Rapamycin and the transcription factor C/EBPβ as a switch in osteoclast differentiation: implications for lytic bone diseases
- (2009) Jeske J. Smink et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Direct control of mitochondrial function by mTOR
- (2009) Arvind Ramanathan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reducing the Risk of Left Ventricular Hypertrophy in Kidney Transplant Recipients: The Potential Role of Mammalian Target of Rapamycin
- (2009) E. Paoletti et al. TRANSPLANTATION PROCEEDINGS
- Design of aging intervention studies: the NIA interventions testing program
- (2008) N. L. Nadon et al. AGE
- Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice
- (2008) Andrew M. Miller et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Reduced Disability and Mortality Among Aging Runners
- (2008) Eliza F. Chakravarty ARCHIVES OF INTERNAL MEDICINE
- mTOR Inhibition by Rapamycin Prevents -Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes
- (2008) M. Fraenkel et al. DIABETES
- Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance
- (2008) G. M. Buyse et al. EUROPEAN HEART JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started